Recent advances of nanovaccines on cancer theranostics
Cancer is a leading cause of death worldwide, with an estimated 20 million new cancer cases and 9.7 million cancer deaths worldwide in 2022. Immunotherapy provides innovative strategies among the most groundbreaking developments in cancer treatment. Cancer vaccines, as a form of immunotherapy, have...
Saved in:
Main Authors: | Xiaobing Yuan, Tianyou Xu, Mubashir Hussain, Bin Liu, Jianwei Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Nanotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnano.2025.1521131/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy
by: Yan Y, et al.
Published: (2025-01-01) -
Nano theranostics involved in bladder cancer treatment
by: Kunpeng Liu, et al.
Published: (2023-04-01) -
A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis
by: Hannaneh Azimizonuzi, et al.
Published: (2025-01-01) -
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01) -
Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
by: Eunbe Ha, et al.
Published: (2025-01-01)